ALAIN SCHREIBER
CIK 1225149 · last filed 2017-04-27
ALAIN SCHREIBER is a corporate insider who has filed 26 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for EGRX, was dated Apr 27, 2017. Across all open-market trades the lifetime net is −$4.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $31.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$31.46M
5
26
-$4.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 18,477 | $2.14 | $39.5K | -$18.94M | 5 | 2017-04-27 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | 10%+ Owner | 4,668,663 | $1.51 | $7.05M | $28.50M | 1 | 2015-01-23 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | 10%+ Owner | 8,100,034 | — | — | -$13.84M | 4 | 2009-10-13 |
| NVD | 10%+ Owner | 6,267,570 | $5.02 | $31.46M | $2.79M | 3 | 2008-12-23 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | Director | 3,013,269 | — | — | -$2.70M | 3 | 2007-09-04 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-27 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | — | -$14.68M | EDGAR |
| 2016-01-05 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-22 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-18 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-23 | AGILE THERAPEUTICS INC (AGRX) Delisted | Buy (P) | +4,871,796 | $28.50M | EDGAR |
| 2014-07-31 | — | Mixed | +10,783,028 | $8.77M | |
| 2014-02-20 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +4,804,118 | $5.00M | EDGAR |
| 2010-04-01 | — | Buy (P) | +33,939,395 | $5.60M | |
| 2010-01-12 | — | Grant (A) | — | $0 | |
| 2009-10-13 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Sell (S) | −3,557,984 | -$8.21M | EDGAR |